Adjuvant Nivolumab Slows Muscle-Invasive Urothelial Carcinoma

MONDAY, June 14, 2021 -- For patients with high-risk muscle-invasive urothelial carcinoma who have had radical surgery, disease-free survival is significantly longer with nivolumab than placebo, according to a study published in the June 3 issue of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news